Antidepressant Cymbalta May Reduce Pain from Chemotherapy-Induced Peripheral Neuropathy (05-24-2013)

The antidepressant Cymbalta® (duloxetine) appears to reduce the numbness and tingling associated with taxane or platinum-based chemotherapy, according to the results of a study published in the Journal of the American Medical Association. Peripheral... Continue Reading

Breast-Conserving Therapy Comparable to Mastectomy for Women with Early-Stage Triple-Negative Breast Cancer (05-23-2013)

In a study of more than 600 women with early-stage triple-negative breast cancer treated at a single institution, treatment with breast-conserving therapy was as effective as total mastectomy. These results were published in Annals of Surgery Oncology. Breast-conserving... Continue Reading

Intermittent Zelboraf Treatment in Patients with Melanoma May Prevent Resistance to the Drug (05-22-2013)

Tumors resistant to Zelboraf® (vemurafenib) in patients with melanoma showed reduced growth after treatment was stopped. What’s more—animal models have shown that drug resistance was prevented by intermittent treatment. These results were presented... Continue Reading

Agenus Announces Initiation of Enrollment in NCI-Sponsored Randomized Trial of Prophage G-200 Vaccine With Avastin in Treatment of Brain Tumors (05-22-2013)

Study Seeking to Enroll 222 Patients; Largest Vaccine Trial Ever Funded by NCI in Brain Tumors and the Largest Cancer Vaccine Study Ever Conducted in Combination With Avastin LEXINGTON, Mass., May 22, 2013 (GLOBE NEWSWIRE) — Agenus Inc. (Nasdaq:AGEN)... Continue Reading

Biomarker Analysis Identifies Women Most Likely to Benefit From Kadcyla (05-20-2013)

Among women with metastatic, HER2-positive breast cancer, those with the highest tumor HER2 levels benefit the most from the drug Kadcyla™ (ado-trastuzumab emtansine, formerly known as T-DM1), according to the results of a study presented at the American... Continue Reading

Novel Two-step Immunotherapy Shows Promise in Recurrent Ovarian Cancer (05-17-2013)

A novel two-step immunotherapy approach yielded clinically beneficial responses in patients with advanced ovarian cancer, according to data from two phase I clinical trials presented at the American Association for Cancer Research (AACR) Annual Meeting... Continue Reading

Following Lifestyle Recommendations Reduces Risk of Cancer Death (05-15-2013)

People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying from several diseases and specifically, a 20 percent... Continue Reading

Genomic Test May Help Guide Prostate Cancer Treatment (05-13-2013)

A new genetic test—the Oncotype DX® Prostate Cancer Test—measures the aggressiveness of prostate cancer and may help scores of men choose between immediate treatment or active surveillance. The test was shown to strongly predict aggressiveness of... Continue Reading

Statins Linked to Lower Risk of Liver Cancer in Hepatitis C (05-8-2013)

People infected with chronic hepatitis C are less likely to develop liver cancer if they are taking statins (cholesterol-lowering drugs), according to the results of a study published in the Journal of Clinical Oncology.[1] The liver is the largest organ... Continue Reading

Anal Cancer Rates Appear to Be On the Rise in the U.S. (05-6-2013)

The number of people in the United States with anal cancer has tripled since the 1970s, according to the results of a study published in the Journal of Clinical Oncology. Anal cancer is an uncommon type of cancer that occurs in the anal canal, the opening... Continue Reading

False-Positive Mammograms Leave a Long-Term Psychological Impact (05-3-2013)

A false-positive mammogram can cause long-term psychosocial harm, according to the results of a study published in the Annals of Family Medicine—in fact, three years later, women still suffer the psychological after-effects of the scare. A mammogram... Continue Reading

Number of Cancer Survivors Expected to Reach 18 Million by 2022 (05-1-2013)

As of January 2012, there were approximately 13.7 million cancer survivors in the United States and that number is expected to rise by 31 percent to 18 million by 2022, according to the second Annual Report on Cancer Survivorship in the United States published... Continue Reading